Recombinant human interleukin-11 is unlikely to stimulate the growth of the most common solid tumors

Anti-Cancer Drugs

Volumn 10, Issue 1, 1999, Pages 97-101

  Soda, Hiroshi ^a   Raymond, Eric ^a   Sharma, Sunil ^a   Lawrence, Richard ^a   Cerna, Cesario ^a   Gomez, Lionel ^a   Schaub, Robert ^b   Von Hoff, Daniel D ^a   Izbicka, Elzbieta ^a,c  

^a CTRC Institute for Drug Development   (United States)

^b PFIZER INC   (United States)

^c University of Texas Health Science Center at San Antonio   (United States)

Author keywords

Cytokine; Human tumor cloning assay; Interleukin 11

Indexed keywords

RECOMBINANT INTERLEUKIN 11;

ARTICLE; CELL PROLIFERATION; COLON CANCER; COLONY FORMING UNIT; GROWTH STIMULATION; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; SOLID TUMOR;

EID: 0032986942     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-199901000-00012     Document Type: Article

References (31)

1. Yang Y-C. Interleukin 11: an overview. Stem Cells 1993; 11: 474-86.
2. Teramura M, Kobayashi S, Yoshinaga K, Iwabe K, Mizoguchi H. Effect of interleukin 11 on normal and pathological thrombopoiesis. Cancer Chemother Pharmacol 1996; 38: S99-S102.
3. Tepler I, Elias L, Smith JWI, et al. A randomized placebo-controlled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapy. Blood 1996; 87: 3607-14.
4. Isaacs C, Roberts N, Loewy J, Kaye JA. Neumega (rhIL-11) prevents platelet transfusions in up to 4 cycles of dose-intense chemotherapy in women with breast cancer. Blood 1996; 88: 448a.
5. Gordon MS, McCaskill-Stevens WJ, Battiato LA, et al. A phase I trial of recombinant human interleukin-11 (Neumega rhIL-11 growth factor) in women with breast cancer receiving chemotherapy. Blood 1996; 87: 3615-24.
6. Du XX, Doerschuk CM, Oraxi A, Williams DA. A bone marrow stromal-derived growth factor, interleukin-11, stimulates recovery of small intestinal musocal cells after cytoablative therapy. Blood 1994; 83: 33-7.
7. Sonis S, Muska A, J OB, Van Vugt A, Langer-Safer P, Keith J. Alteration in the frequency, severity, and duration of chemotherapy-induced mucositis in hamsters by interleukin-11. Eur J Cancer 1995; 31B: 261-6.
8. Nandurkar HH, Hilton DJ, Nathan P, Wilson T, Nicola N, Begley CG. The human IL-11 receptor requires gp130 for signaling: demonstration of molecular cloning of the receptor. Oncogene 1996; 12: 585-93.
9. Douglas AM, Goss GA, Sutherland RL, et al. Expression and function of members of the cytokine receptor superfamily on breast cancer cells. Oncogene 1997; 14: 661-9.
10. Gupta N, Finley G, Meisler A, Dagnal E, Melhem M. Interleukin-11 expression in normal and malignant colorectal epithelium. Proc Am Ass Cancer Res 1997; 38: 554.
11. Paglia D, Oran A, Lu C, Kerbel RS, Sauder DN, McKenzie RC. Expression of leukemia inhibitory factor and interleukin-11 by human melanoma cell lines: LIF, IL-6, and IL-11 are not coregulated. J Interf Cytokine Res 1995; 15: 455-60.
12. Guillaume T, Sekhavat M, Rubinstein DB, Hamdan O, Symann ML. Transcription of genes encoding granulocytemacrophage colony-stimulating factor, interleukin 3, and interleukin 6 receptors and lack of proliferative response to exogenous cytokines in nonhematopoietic human malignant cell lines. Cancer Res 1993; 53: 3139-44.
13. Hu JP, Cesano A, Santoli D, Clark SC, Hoang T. Effects of interleukin-11 on the proliferation and cell cycle status of mycloid leukemic cells. Blood 1993; 81: 1586-92.
14. Kobayashi S, Teramura M, Sugawara I, Oshim K, Mizoguchi H. Interleukin-11 acts as autocrine growth factor for human megakaryoblastic cell lines. Blood 1993; 81: 889-93.
15. Zhang XG, Gu JJ, Lu ZY, et al. Ciliary neurotropic factor, interleukin 11, leukemia inhibitory factor, and oncostatin M are growth factors for human myeloma cell lines using the interleukin 6 signal transducer GP130. J Exp Med 1994; 177: 1337-42.
16. Von Hoff DD, Forseth BJ, Huong M, Buchok JB, Lathan B. Improved plating efficiencies for human tumors cloned in capillary tubes versus petri dishes. Cancer Res 1986; 46: 4012-7.
17. Von Hoff DD, Marshall M, Chacon D, et al. Cloning of primary human tumor colony forming units in glass capillaries. J Tiss Culture Methods 1992; 13: 125-31.
18. Aoyama K, Uchida T, Takanuki F, et al. Pharmacokinetics of recombinant human interleukin-11 (rhIL-11) in healthy male subjects. Br J Clin Pharmacol 1997; 43: 571-8.
19. Broudy VC, Lin NL, Fox N, Taga T, Saito M, Kaushansky K. Thrombopoietin stimulates colony-forming unit-megakaryocyte proliferation and megakaryocyte maturation independently of cytokines that signal through the gp130 receptor subunit. Blood 1996; 88: 2026-32.
20. Teramura M, Kohayashi S, Hoshino S, Oshimi K, Mizoguchi H. Interleukin-11 enhances human megakaryocytopoiesis in vitro. Blood 1992; 79: 327-31.
21. Hanauske U, Hanauske A, Marshall MH, Muggia VA, Von Hoff DD. Biphasic effect of vanadium salts on in vitro tumor colony growth. Int J Cell Cloning 1987; 5: 170-8.
22. Manni A, Wright C, Pontari M, Fell P, Joehl R. Hormone dependency of human breast neoplasms cultured in vitro in the stem cell assay. J Natl Cancer Inst 1985; 74: 767-70.
23. Singletary SE, Tomosovic B, Spitzer G, Tucker SL, Hug V, Drewinko B. Effects and interactions of epidermal growth factor, insulin, hydrocortisone, and estradiol on the cloning of human tumor cells. Int J Cell Cloning 1985; 3: 407-14.
24. Pathak MA, Matrisian LM, Magun BE, Salmon SE. Effect of epidermal growth actor on clonogenic growth of primary human tumor cells. Int J Cancer 1982; 30: 745-50.
25. Hanauske A-R, Hanauske U, Buchok J, Von Hoff DD. Recombinant human transforming growth factor-alpha stimulates in vitro colony formation of fresh human tumor specimens. Int J Cell Cloning 1988; 6: 221-9.
26. Kern DH, Chien FW, Morton DL. Selective effects of insulin and hydrocortisone on colony formation and chemosensitivity of human tumors in soft agar. Int J Cancer 1984; 33: 807-12.
27. Foulke RS, Marshall MH, Trotta PP, Von Hoff DD. In vitro assessment of the effects of granulocyte-macrophage colony stimulating factor on primary human tumors and derived lines. Cancer Res 1990; 50: 6264-7.
28. Isaacs C, Robert N, Bailey F, et al. Randomized placebo-controlled study of recombinant human interleukin-11 to prevent chemotherapy-induced thrombocytopenia in patients with breast cancer receiving dose-intensive cyclophosphamide and doxorubicin. J Clin Oncol 1997; 15: 3368-77.
29. Koo AS, Armstrong C, Bochner B, et al. Interleukin-6 and renal cell cancer: production, regulation, and growth effects. Cancer Immunol Immunother 1992; 35: 97-105.
30. Ravoct C, De Greve J, Vandewoude K, et al. Tumor stimulating effects of recombinant human interleukin-6. Lancet 1994; 344: 1576-7.
31. Bast RCJ, Boyer CM, Jacobs I, et al. Cell growth regulation in epithelial ovarian cancer. Cancer 1993; 71: 1597-601.